acetyl-dl-leucine has been researched along with Autosomal Dominant Cerebellar Ataxia, Type II in 1 studies
acetylleucine: used for treating vestibular-related imbalance and vertigo
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Feil, K | 1 |
Adrion, C | 1 |
Teufel, J | 1 |
Bösch, S | 1 |
Claassen, J | 1 |
Giordano, I | 1 |
Hengel, H | 1 |
Jacobi, H | 1 |
Klockgether, T | 1 |
Klopstock, T | 1 |
Nachbauer, W | 1 |
Schöls, L | 1 |
Stendel, C | 1 |
Uslar, E | 1 |
van de Warrenburg, B | 1 |
Berger, I | 1 |
Naumann, I | 1 |
Bayer, O | 1 |
Müller, HH | 1 |
Mansmann, U | 1 |
Strupp, M | 1 |
1 trial available for acetyl-dl-leucine and Autosomal Dominant Cerebellar Ataxia, Type II
Article | Year |
---|---|
Effects of acetyl-DL-leucine on cerebellar ataxia (ALCAT trial): study protocol for a multicenter, multinational, randomized, double-blind, placebo-controlled, crossover phase III trial.
Topics: Adult; Cerebellar Ataxia; Cross-Over Studies; Double-Blind Method; Humans; Leucine; Psychiatric Stat | 2017 |